These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36440784)

  • 21. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial.
    Peloso PM; Fortin L; Beaulieu A; Kamin M; Rosenthal N;
    J Rheumatol; 2004 Dec; 31(12):2454-63. PubMed ID: 15570651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of quality of life following treatment with etoricoxib in patients with arthritis or low-back pain: an open label, uncontrolled pilot study in Mexico.
    Ramos-Remus CR; Hunsche E; Mavros P; Querol J; Suarez R
    Curr Med Res Opin; 2004 May; 20(5):691-8. PubMed ID: 15140335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.
    Birbara CA; Puopolo AD; Munoz DR; Sheldon EA; Mangione A; Bohidar NR; Geba GP;
    J Pain; 2003 Aug; 4(6):307-15. PubMed ID: 14622687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study.
    Ruoff GE; Rosenthal N; Jordan D; Karim R; Kamin M;
    Clin Ther; 2003 Apr; 25(4):1123-41. PubMed ID: 12809961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decision making in surgical treatment of chronic low back pain: the performance of prognostic tests to select patients for lumbar spinal fusion.
    Willems P
    Acta Orthop Suppl; 2013 Feb; 84(349):1-35. PubMed ID: 23427903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain: A Systematic Review and Meta-analysis.
    Abdel Shaheed C; Maher CG; Williams KA; Day R; McLachlan AJ
    JAMA Intern Med; 2016 Jul; 176(7):958-68. PubMed ID: 27213267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The assessment of the clinical efficacy and tolerability of complex treatment of patients with acute low-back pain].
    Dadasheva MN; Gorenkov RV; Zolotovskaya IA; Dadasheva KN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(9):47-52. PubMed ID: 33081446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain.
    Schattenkirchner M; Milachowski KA
    Clin Rheumatol; 2003 May; 22(2):127-35. PubMed ID: 12740678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Safety and Tolerability of NKTR-181 in Patients with Moderate to Severe Chronic Low Back Pain or Chronic Noncancer Pain: A Phase 3 Multicenter, Open-Label, 52-Week Study (SUMMIT-08 LTS).
    Gudin J; Rauck R; Argoff C; Agaiby E; Gimbel J; Katz N; Doberstein SK; Tagliaferri M; Tagliaferri M; Potts J; Wild J; Lu L; Siddhanti S; Hale M; Markman J
    Pain Med; 2020 Nov; 21(7):1347-1356. PubMed ID: 31361019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial.
    Buynak R; Rappaport SA; Rod K; Arsenault P; Heisig F; Rauschkolb C; Etropolski M
    Clin Ther; 2015 Nov; 37(11):2420-38. PubMed ID: 26428249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term, prolonged-release oral tapentadol for the treatment of refractory chronic low back pain: a single-center, observational study.
    Finco G; Mura P; Musu M; Deidda C; Saba M; Demelas I; Evangelista M; Sardo S
    Minerva Med; 2018 Aug; 109(4):259-265. PubMed ID: 29947490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
    Petzke F; Welsch P; Klose P; Schaefert R; Sommer C; Häuser W
    Schmerz; 2015 Feb; 29(1):60-72. PubMed ID: 25503883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Back School programme for nurses has reduced low back pain levels: A randomised controlled trial.
    Járomi M; Kukla A; Szilágyi B; Simon-Ugron Á; Bobály VK; Makai A; Linek P; Ács P; Leidecker E
    J Clin Nurs; 2018 Mar; 27(5-6):e895-e902. PubMed ID: 28771864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between centralization, depression, somatization, and disability among patients with nonspecific low back pain.
    Edmond SL; Werneke MW; Hart DL
    J Orthop Sports Phys Ther; 2010 Dec; 40(12):801-10. PubMed ID: 20972348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II Study.
    Sanga P; Polverejan E; Wang S; Kelly KM; Thipphawong J
    Clin Ther; 2016 Jun; 38(6):1435-1450. PubMed ID: 27101815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain.
    Gordon A; Rashiq S; Moulin DE; Clark AJ; Beaulieu AD; Eisenhoffer J; Piraino PS; Quigley P; Harsanyi Z; Darke AC
    Pain Res Manag; 2010; 15(3):169-78. PubMed ID: 20577660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Willow bark extract STW 33-I in the long-term treatment of outpatients with rheumatic pain mainly osteoarthritis or back pain.
    Uehleke B; Müller J; Stange R; Kelber O; Melzer J
    Phytomedicine; 2013 Aug; 20(11):980-4. PubMed ID: 23731658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Effectiveness and Tolerability of Pain Treatment with Tapentadol Prolonged Release.
    Mateos RG; Bernal DS; Morera LMT; Ferri CM; Escobar AE
    Pain Physician; 2021 Jan; 24(1):E75-E85. PubMed ID: 33400440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of piroxicam-beta-cyclodextrin in the outpatient management of chronic back pain.
    Pijak MR; Turcani P; Turcaniova Z; Buran I; Gogolak I; Mihal A; Gazdik F
    Bratisl Lek Listy; 2002; 103(12):467-72. PubMed ID: 12696775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.